Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Ottawa

$27,000.00

Exploring the role of ZBTB10 in the regulation of alpha-synuclein levels and pathology

EF 2025-26

Résumé
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the accumulation of alpha-synuclein (aSyn) protein aggregates, which contribute to neuronal dysfunction and motor impairments. While elevated expression of the SNCA gene, which encodes aSyn, is strongly implicated in PD pathogenesis, the transcriptional regulators that control SNCA expression remain poorly understood. Identifying these regulators is critical for uncovering new therapeutic strategies. My project investigates ZBTB10 as a potential transcriptional activator of SNCA and its role in modulating aSyn levels and pathology. To test this, I am using an adeno-associated virus (AAV)-based CRISPR approach to knock down ZBTB10 in postnatal day 0 (P0) mouse pups. These mice, which carry a PD-associated aSyn mutation, will then be analyzed for aSyn protein levels, aggregation, and related neuropathology. In addition, I will assess whether ZBTB10 knockdown mitigates PD-like behavioural phenotypes, providing insight into its functional role in disease progression. This work has the potential to identify ZBTB10 as a novel regulator of SNCA and aSyn pathology, advancing our understanding of PD mechanisms. Ultimately, these findings could help pave the way for new therapeutic strategies aimed at reducing aSyn burden and slowing disease progression.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573046
Name
Mullin Makenzie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the role of ZBTB10 in the regulation of alpha-synuclein levels and pathology
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
A53t Mutation; Aav; Alpha-Synuclein; Behavioural Phenotypes; Neurodegeneration; Parkinson'S; Pathology; Phosphorylated Alpha-Synuclein; Protein Aggregation; Zbtb10
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the accumulation of alpha-synuclein (aSyn) protein aggregates, which contribute to neuronal dysfunction and motor impairments. While elevated expression of the SNCA gene, which encodes aSyn, is strongly implicated in PD pathogenesis, the transcriptional regulators that control SNCA expression remain poorly understood. Identifying these regulators is critical for uncovering new therapeutic strategies. My project investigates ZBTB10 as a potential transcriptional activator of SNCA and its role in modulating aSyn levels and pathology. To test this, I am using an adeno-associated virus (AAV)-based CRISPR approach to knock down ZBTB10 in postnatal day 0 (P0) mouse pups. These mice, which carry a PD-associated aSyn mutation, will then be analyzed for aSyn protein levels, aggregation, and related neuropathology. In addition, I will assess whether ZBTB10 knockdown mitigates PD-like behavioural phenotypes, providing insight into its functional role in disease progression. This work has the potential to identify ZBTB10 as a novel regulator of SNCA and aSyn pathology, advancing our understanding of PD mechanisms. Ultimately, these findings could help pave the way for new therapeutic strategies aimed at reducing aSyn burden and slowing disease progression.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mullin, Makenzie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~